The principle goal was to detect suited analytical targets by examining human hepatocyte incubation samples with high-resolution mass spectrometry (HRMS) and to substantiate the outcome in authentic urine specimens and to ascertain AB-FUBINACA's metabolic security in human liver microsomes and in comparison hepatocyte and urine effects with in sili